iRadimed Corp (IRMD)
49.90
+0.71
(+1.44%)
USD |
NASDAQ |
Nov 05, 09:33
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 632.40M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 11.44% |
| Valuation | |
| PE Ratio | 34.18 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 8.927 |
| Price to Book Value | 7.580 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.15 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 56.72% |
Profile
| iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States. |
| URL | https://www.iradimed.com |
| Investor Relations URL | https://www.iradimed.com/investors/events |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Feb. 07, 2025 (est.) |
| Last Earnings Release | Oct. 31, 2024 |
| Next Ex-Dividend Date | Nov. 15, 2024 |
| Last Ex-Dividend Date | Aug. 20, 2024 |
Ratings
Profile
| iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States. |
| URL | https://www.iradimed.com |
| Investor Relations URL | https://www.iradimed.com/investors/events |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Feb. 07, 2025 (est.) |
| Last Earnings Release | Oct. 31, 2024 |
| Next Ex-Dividend Date | Nov. 15, 2024 |
| Last Ex-Dividend Date | Aug. 20, 2024 |